Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin.
Open Access
- 1 April 1990
- journal article
- research article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 110 (4) , 1361-1367
- https://doi.org/10.1083/jcb.110.4.1361
Abstract
Medium conditioned by Chinese hamster ovary (CHO) cells transfected with the simian pre-pro-TGF.beta.1 cDNA contains high levels of latent TGF.beta.1. The amino-terminal region of the TGF.beta.1 precursor is secreted and can be detected in the conditioned medium by immunoblotting using peptide antibodies specific for amino-terminal peptides. Chemical cross-linking of CHO-conditioned medium using bis-(sulfosuccinimidyl)-suberate (BS3) followed by immunoblot analyses indicates that latent recombinant TGF.beta.1 contains both the cleaved amino-terminal glycopeptide and mature TGF.beta.1 polypeptide in a noncovalent association and that this association confers latency. The data presented here do not support the involvement of a unique TGF.beta. binding protein(s) in latent recombinant TGF.beta.1. Plasmin treatment of CHO-conditioned medium resulted in the appearance of TGF.beta. competing activity. In addition, immunoblot analysis of plasmin-treated CHO-conditioned medium indicates that the amino-terminal glycopeptide is partially degraded and that mature TGF.beta.1 is released. Thus, activation of latent TGF.beta.1 may occur by proteolytic nicking within the amino-terminal glycopeptide thereby causing a disruption of tertiary structure and noncovalent bonds, which results in the release of active, mature TGF.beta.1. Acid activation of latent TGF.beta., in comparison, appears to be due to association of the amino-terminal glycopeptide from the mature polypeptide.Keywords
This publication has 24 references indexed in Scilit:
- Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization.Journal of Biological Chemistry, 1988
- Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-betaThe Journal of cell biology, 1988
- A New Prosomatostatin-Derived Peptide Reveals a Pattern for Prohormone Cleavage at Monobasic SitesScience, 1987
- Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.The Journal of cell biology, 1986
- Transforming growth factor β alters plasminogen activator activity in human skin fibroblastsExperimental Cell Research, 1986
- β-Transforming Growth Factor is stored in human blood platelets as a latent high molecular weight complexBiochemical and Biophysical Research Communications, 1986
- Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditionsBiochemical and Biophysical Research Communications, 1985
- Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cellsNature, 1985
- Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.Proceedings of the National Academy of Sciences, 1984
- Normal embryo fibroblasts release transforming growth factors in a latent formJournal of Cellular Physiology, 1984